Project CBD

MARCH 21, 2023

Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

FEBRUARY 6, 2024

The CRC unveiled proposed regulations in September 2023, aiming to expand allowable forms of ingestible cannabis products in both medical and recreational markets to include cannabis-infused beverages, baked goods, candies, gummies, butter, jams, jellies, and chocolates. The public comment period is open from October 16 to December 15, 2023.

Programs 67

Programs Access Dispensary Chronic Pain 67

Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

LifeCannMD

NOVEMBER 21, 2022

Coming in 2023, Floridians will be able to purchase another item at the pump! PTSD, Cancer, Epilepsy, and more. In partnership with Chicago-based Green Thumb, ten Circle K stores in Miami will begin selling medical cannabis products next year.

Chronic Pain 52

Chronic Pain Epilepsy Dispensary Conditions 52

MMJ Recs

DECEMBER 13, 2023

However, the tide began to turn in 2015 when the state legislature passed the Compassionate Use Act, allowing for the limited use of low-THC cannabis for patients with intractable epilepsy. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

The Cannigma

JULY 12, 2022

A representative from the Alabama Agriculture Department has stated that licenses for medical marijuana producers won’t be issued before September 2022, and it could take until 2023 to get the program up and running. Possible penalties for cannabis.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

MJ Business Attorneys

JULY 29, 2019

CBD sales by 2023. As of right now, the only cannabis-based medication officially recognized by the FDA is the CBD oral solution Epidiolex, which is used to treat two rare forms of childhood-onset epilepsy. The CBD industry has not slowed despite the regulatory headaches that come with selling the products. billion is U.S.

CBD 133

CBD Pets Media Food 133

Veriheal

SEPTEMBER 15, 2023

Finally, on April 28, 2023, the first licensed sales commenced with the opening of dispensaries in Marietta and Macon. The medical conditions that qualify for this program typically include severe and debilitating conditions like epilepsy, cancer, multiple sclerosis, and Parkinson’s disease, among others.

Programs 62

Programs Legalization Oil Conditions 62

The Cannigma

SEPTEMBER 8, 2022

In the 2022 legislative session, there were two cannabis bills introduced: one would decriminalize possession of up to three ounces of cannabis and the other would create a medical cannabis program, however, these are not expected to see movement until 2023 at the earliest. CBD regulations.

Law 75

Law Supply Chain Programs Concentrates 75

Veriheal

JANUARY 12, 2023

Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023. Another groundbreaking move occurred in March of last year when the European country’s medical cannabis pilot project kicked off.

Medicine 95

Medicine Chronic Pain Consumption Cannabis 95

Veriheal

MARCH 31, 2023

Fast-forward to 2023, and the state has now granted the first of these psilocybin manufacturing licenses to Satori Farms PDX LLC. Oregon and Maryland Make Psychedelic Progress Psychedelic history is being made on both coasts as Oregon and Maryland inch closer to legal use. Let us know in the comments!

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

The Cannigma

JULY 5, 2022

Despite having 20,000 registered patients in March of 2022, there are no licensed producers or distributors of cannabis products and sales are unlikely to start before mid-2023 at the earliest. In-state cultivation and distribution weren’t legalized until 2019. The state has accepted applications for producers but has not issued any licenses.

Law 96

Law Decriminalization Programs Patients 96

PrestoDoctor

FEBRUARY 13, 2023

Louis Skyline – Gateway Arch Getting your Missouri medical marijuanas card in 2023 is still beneficial. Beginning May 3rd, 2023, dispensaries will be required to scan patient and caregiver cards at the time of purchase. Luckily, Prestodoctor has Missouri medical marijuana doctors on standby waiting to assist you.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. Starting in 2023, the bill would allow for industrial hemp and medical cannabis production on up to 150 hectares of land.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

Cannabis Law Report

DECEMBER 9, 2019

In fact, the Brightfield Group claims that the CBD market may reach $24 billion by 2023, good news for businesses such as Next Green Wave, Inc. The supplement has already been adopted by millions of consumers and boasts a growth trajectory that has investors foaming at the mouth to get in on the action. Anxiety and Inflammation Lead the Pack.

Pets 59

Pets CBD Research and Development Epilepsy 59

The Joint Blog

JANUARY 12, 2020

billion by 2023, according to the cannabis research firm Brightfield Group and noted by the AP. ” “The results of our first epilepsy study were promising, but there was certainly not enough data to say CBD is the new miracle anti-convulsive drug in dogs,” McGrath said. Amy Carter of St.

Pets 36

Pets CBD Clinical Trials Research and Development 36

United Patients Group

MARCH 10, 2023

He was born in 1930 and died in 2023, at age 92. He died March 10th 2023 from complications from Parkinson’s Disease at 93 years old after living a full life with an incredible legacy of scientific discovery. The post RIP Cannabis Pioneer Raphael Mechoulam November 1930 – March 2023 appeared first on United Patients Group.

Cannabinoids 98

Cannabinoids THC Sativa CBD 98

Veriheal

JUNE 22, 2023

Background of the Case The case involved a 21-year-old defendant facing a DUI charge in early 2023. The legislation permits physicians to recommend cannabis for treating a range of severe medical conditions, such as epilepsy , PTSD , cancer, and glaucoma , to name a few.

Patients 75

Patients Treatment Conditions Cannabis 75

Cannabis Law Report

DECEMBER 30, 2019

Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy. The law will take effect on January 1, 2020. State lawmakers passed Assembly Bill 20 , which institutes various changes to the state’s medical access program.

Legislation 59

Legislation Patients Access Banking 59